Bian R, Yuan J, Xu H (2012) The case-control study of the influencing factors of drug induced arrhythmias. Chin J Pharmacoepidemiol 21(10):477–479

Google Scholar 

Song W, Liu T (2020) Interpretation of the 2020 American Heart Association scientific statement on drug-induced arrhythmias. Chin J Evid Based Cardiovasc Med 12(11):1281–1282

Google Scholar 

Tisdale JE, Chung MK, Campbell KB et al (2020) Drug-induced arrhythmias: a scientific statement from the American Heart Association. Circulation 142(15):e214–214e233

Vanneman MW, Madhok J, Weimer JM et al (2021) Perioperative implications of the 2020 American Heart Association scientific statement on drug-induced arrhythmias-a focused review. J Cardiothorac Vasc Anesth 36(4):952–961

Moreland-Head LN, Coons JC, Seybert AL et al (2021) Use of disproportionality analysis to identify previously unknown drug-associated causes of cardiac arrhythmias using the Food and Drug Administration Adverse Event Reporting System (FAERS) database. J Cardiovasc Pharmacol Ther 26(4):341–348

Article  PubMed  Google Scholar 

Kong X, Guo D, Liu S et al (2021) Incidence, characteristics and risk factors for drug-induced liver injury in hospitalized patients: a matched case-control study. Br J Clin Pharmacol 87(11):4304–4312

Article  CAS  PubMed  Google Scholar 

Yu C, Guo D, Yao C et al (2021) Development and validation of a nomogram for predicting drug-induced acute kidney injury in hospitalized patients: a case-control study based on propensity-score matching. Front Pharmacol 12:657853

Article  PubMed  PubMed Central  Google Scholar 

Liu S, Guo D, Kong X et al (2021) Analysis of the characteristics and risk factors of suspected drug-induced allergic reactions in 201299 hospitalized patients. Chin J Pharmacoepidemiol 30(06):382–387

CAS  Google Scholar 

Guo D, Yu C (2021) Expert consensus on automated surveillance and evaluation of clinical medication risk based on hospital information system data. Chin J Drug Appl Mon 18(5):277–287

Google Scholar 

Guo H, Guo D, Gao A et al (2022) Establishment and validation of automatic monitoring module for drug-induced arrhythmia based on data of HIS. Chin J Drug Appl Mon 19(3):176–181

Google Scholar 

Yu C, Guo D, Yao C et al (2020) Clinical characteristics of hospitalized patients with drug-induced acute kidney injury and associated risk factors: a case-control study. Biomed Res Int 2020:9742754

Article  PubMed  PubMed Central  Google Scholar 

Li B, Gao R, Li R et al (2014) Causal determination of the adverse events and adverse drug reactions in drug clinical trials. Chin J New Drugs 23(12):1465–1470

Google Scholar 

Arnar DO, Mairesse GH, Boriani G et al (2019) Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS). Europace 21(6):844–845

Article  PubMed  Google Scholar 

Schwartz PJ, Woosley RL (2016) Predicting the unpredictable: drug-induced QT prolongation and torsades de pointes. J Am Coll Cardiol 67(13):1639–1650

Article  PubMed  Google Scholar 

Vlachos K, Georgopoulos S, Efremidis M et al (2016) An update on risk factors for drug-induced arrhythmias. Expert Rev Clin Pharmacol 9(1):117–127

Article  CAS  PubMed  Google Scholar 

Trinkley KE, Rlii P, Lien H et al (2013) QT interval prolongation and the risk of torsades de pointes: essentials for clinicians. Curr Med Res Opin 29(12):1719–1726

Article  PubMed  Google Scholar 

Klotzbaugh RJ, Martin A, Turner JR (2020) Drug-induced proarrhythmia: discussion and considerations for clinical practice. J Am Assoc Nurse Pract 32(2):1–7

Article  Google Scholar 

Tong R, He Z, Cheng M et al (2020) Effects of levofloxacin on QTc interval of the patients with type 2 diabetes mellitus and infection. Pharm Clin Res 28(02):110–112

Google Scholar 

Guo H, Guo D, Liu S et al (2021) Analysis of 1 439 cases of drug-induced arrhythmia. Chin J Pharmacoepidemiol 30(3):181–186

CAS  Google Scholar 

Bulletin DAT (2016) QT interval and drug therapy. BMJ 353:i2732

Google Scholar 

Lee A, Pickham D (2016) Basic cardiac electrophysiology and common drug-induced arrhythmias. Crit Care Nurs Clin North Am 28(3):357

Article  PubMed  Google Scholar 

Lapi F, Wilchesky M, Kezouh A et al (2012) Fluoroquinolones and the risk of serious arrhythmia: a population-based study. Clin Infect Dis 55(11):1457–1465

Article  CAS  PubMed  Google Scholar 

Gorelik E, Masarwa R, Perlman A et al (2019) Fluoroquinolones and cardiovascular risk: a systematic review, meta-analysis and network meta-analysis. Drug Saf 42(4):529–538

Article  CAS  PubMed  Google Scholar 

Shojaei L, Ruzbahani M, Khajavian S et al (2020) Analysis of QTc Interval during levofloxacin prescription in cardiac patients with pneumonia. Curr Drug Saf 15(2):111–116

Article  PubMed  Google Scholar 

Alexandre J, Moslehi JJ, Bersell KR et al (2018) Anticancer drug-induced cardiac rhythm disorders: Current knowledge and basic underlying mechanisms. Pharmacol Ther 189:89–103

Article  CAS  PubMed  Google Scholar 

Tricco AC, Soobiah C, Blondal E et al (2015) Comparative safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysis. BMC Med 13:142

Article  PubMed  PubMed Central  Google Scholar 

van Mourik MS, Troelstra A, van Solinge WW et al (2013) Automated surveillance for healthcare-associated infections: opportunities for improvement. Clin Infect Dis 57(1):85–93

Article  PubMed  Google Scholar 

Chen C, Jia W, Guo D et al (2020) Development of a computer-assisted adverse drug events alarm and assessment system for hospital inpatients in China. Ther Innov Regul Sci 54(1):32–41

Article  PubMed  Google Scholar 

Hu P, Guo D, Jia W et al (2018) Intelligentialized real-time surveillance study on adverse drug reactions caused by cinepazide maleate. Chin J Drug Appl Mon 15(2):92–95

Google Scholar